Welcome to our dedicated page for Gaxos.ai news (Ticker: $GXAI), a resource for investors and traders seeking the latest updates and insights on Gaxos.ai stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Gaxos.ai's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Gaxos.ai's position in the market.
Rhea-AI Summary
Gaxos Health, a subsidiary of Gaxos.ai Inc., has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell. Dr. Margolis brings over 25 years of experience in urology, focusing on men's health and regenerative therapies. Dr. Pavell specializes in physical medicine and rehabilitation, offering advanced non-operative treatments. The addition of these top medical talents demonstrates Gaxos Health's commitment to providing innovative solutions and creating value for shareholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6%
Tags
-
Rhea-AI Summary
Gaxos.ai Inc. (NASDAQ: GXAI) has regained compliance with the minimum bid price requirement under NASDAQ Listing Rule 5550(a)(2) for continued listing on the NASDAQ Capital Market. The Company's common stock traded above $1.00 for 10 consecutive days as of March 21, 2024, resolving the non-compliance issue.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.39%
Tags
-
Rhea-AI Summary
Gaxos.ai Inc. (GXAI) closed a private placement offering, selling 628,367 shares of common stock, series A warrants, and short-term series B warrants at $5.57 per share. The gross proceeds were $3.5 million. H.C. Wainwright & Co. acted as the exclusive placement agent. The company plans to use the net proceeds for working capital and general corporate purposes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.59%
Tags
Rhea-AI Summary
Gaxos.ai Inc. (NASDAQ: GXAI) announced a private placement of common stock and warrants, totaling 628,367 shares, at a purchase price of $5.57 per share. The series A and short-term series B warrants have exercise prices of $5.50 per share and expire at different intervals. The private placement is set to close soon.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
51.13%
Tags
-
Rhea-AI Summary
Gaxos.ai Inc. acquires AI technology from Ultiself to enhance Gaxos Health's offerings, aiming to provide customized solutions in the health and wellness industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
51.13%
Tags
-
News
Rhea-AI Summary
Gaxos.ai Inc. (NASDAQ: GXAI) announces a 1-for-12 reverse stock split effective March 7, 2024, consolidating every 12 shares into 1 share. The Company's common stock will trade on a post-split basis under the same symbol 'GXAI' on The Nasdaq Capital Market. The reverse split aims to streamline the share structure, with approximately 981,523 shares outstanding post-split.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.82%
Tags
Rhea-AI Summary
Gaxos.ai Inc. announces the formation of a medical advisory board within its health and wellness division, Gaxos Health, led by Dr. Nate Lebowitz, M.D. The board aims to provide expertise in product development and strategic opportunities for creating shareholder value.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.36%
Tags
-
Rhea-AI Summary
Gaxos.ai Inc. announces the launch of an artificial intelligence solution for game developers through Gaxos Gaming, aiming to revolutionize game development with AI-powered creativity, seamless integration, dynamic content generation, and customized solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
177.25%
Tags
-
News
Rhea-AI Summary
Gaxos.ai Inc. announces a strategic expansion with a dual-division structure, Gaxos Gaming and Gaxos Health, focusing on AI applications in gaming and health sectors. Gaxos Health aims to revolutionize personal health and wellness through AI-powered health optimization solutions, personalized wellness strategies, and data-driven health plans. The company also launched four games in 2023, with plans for more in 2024, and has successfully repurchased and cancelled 244,184 shares of its common stock under a share buyback program. Additionally, the company has changed its name to Gaxos.ai Inc. and is now trading under the ticker symbol GXAI on the Nasdaq Capital Market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.62%
Tags
Rhea-AI Summary
Gaxos.AI (Gaxos) unveils a revolutionary initiative to enhance mental and physical health, combat loneliness, and promote longevity through a suite of artificial intelligence applications. Leveraging cutting-edge AI, Gaxos.AI aims to offer meaningful support in mental and physical health, companionship, coaching, and tailored guidance for improving overall wellbeing. CEO Vadim Mats emphasizes the expansion into mental health and companionship, aligning with the long-term vision of creating solutions that deeply resonate with people globally.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.33%
Tags
Gaxos.ai Inc.
Nasdaq:GXAI
GXAI Rankings
GXAI Stock Data
4.54M
1.09M
Services-prepackaged Software
United States of America
ROSELAND